In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency

Clinical and Experimental Medicine

Volumn 10, Issue 1, 2010, Pages 27-31

  Artac, Hasibe ^a   Kara, Reyhan ^a   Reisli, Ismail ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

CD25; Common variable immunodeficiency; Fas (CD95); Intravenous immunoglobulin; T cells

Indexed keywords

CD69 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIGENS, CD95; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; T-LYMPHOCYTES; YOUNG ADULT;

EID: 74949128394     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0061-1     Document Type: Article

References (29)

1. R Lemieux R Bazin N Sonia 2005 Therapeutic intravenous immunoglobulins Mol Immunol 42 839 848 10.1016/j.molimm.2004.07.046 1:CAS:528: DC%2BD2MXjtFOmtbc%3D 15829272 (Pubitemid 40489033)
2. J Bayry N Misra V Latry F Prost S Delignat S Lacroix-Desmazes MD Kazatchkine SV Kaveri 2003 Mechanisms of action of intravenous immunoglobulins in autoimmune and inflammatory diseases Transfus Clin Biol 10 165 169 10.1016/S1246-7820(03)00035-1 1:STN:280:DC%2BD3s3ntlCgug%3D%3D 12798851 (Pubitemid 36734108)
3. MD Kazatchkine SV Kaveri 2001 Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 747 755 10.1056/NEJMra993360 1:CAS:528:DC%2BD3MXmvFKjsLg%3D 11547745 (Pubitemid 34936657)
4. JF Seite Y Shoenfeld P Youinou S Hillion 2008 What is the content of the magic draft IVIg? Autoimmun Rev 7 435 439 10.1016/j.autrev.2008.04.012 18558358
5. T Sapir Y Shoenfeld 2005 Facing the enigma of immunomodulatory effects of intravenous immunoglobulin Clin Rev Allergy Immunol 29 185 199 10.1385/CRIAI:29:3:185 1:CAS:528:DC%2BD28XosVOqtw%3D%3D 16391393 (Pubitemid 43041669)
6. S Nagata P Golstein 1995 The Fas death factor Science 267 1449 1456 10.1126/science.7533326 1:CAS:528:DyaK2MXktlClt7w%3D 7533326
7. NK Prasad G Papoff A Zeuner E Bonnin MD Kazatchkine G Ruberti SV Kaveri 1998 Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway J Immunol 161 3781 3790 1:CAS:528: DyaK1cXmsFahtL0%3D 9759905
8. F Altznauer S Von Gunter P Spath HU Simon 2003 Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations J Allergy Clin Immunol 112 1185 1190 10.1016/j.jaci.2003.09.045 1:CAS:528:DC%2BD2cXhtlGgsbc%3D 14657880 (Pubitemid 37550013)
9. I Viard P Wehrli R Bullani P Schneider N Holler D Salomon T Hunziker JH Saurat J Tschopp LE French 1998 Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 490 493 10.1126/science.282.5388.490 1:CAS:528:DyaK1cXmslegsbo%3D 9774279 (Pubitemid 28483679)
10. LE French 2006 Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding Allergol Int 55 9 16 10.2332/allergolint.55.9 17075281
11. International Union of Immunological Societies 1999 Primary immunodeficiency diseases. Report of an IUIS Scientific Committee Clin Exp Immunol 118 suppl 1 1 28
12. WA Sewell ME North R Cambronero AD Webster J Farrant 1999 In vivo modulation of cytokine synthesis by intravenous immunoglobulin Clin Exp Immunol 116 509 515 10.1046/j.1365-2249.1999.00924.x 1:CAS:528:DyaK1MXjvFOrs7w%3D 10361243 (Pubitemid 29258104)
13. WB White CR Desbonnet M Ballow 1987 Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia Am J Med 81 431 436 10.1016/0002-9343(87)90752-2 (Pubitemid 18109901)
14. M Ballow W White C Desbonnet 1989 Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immunoglobulin J Allergy Clin Immunol 84 595 601 10.1016/0091-6749(89)90196-6 1:STN:280:DyaK3c%2FgvFOrtw%3D%3D 2571628
15. D Berlana A Vidaller R Jódar E Fort A Domingo L Pastó 2005 Changes in biochemical, hematological and immunological profiles after low-dose intravenous immunoglobulin administration in patients with hypogammaglobulinemia Transfus Clin Biol 12 433 440 10.1016/j.tracli.2006.02.023 16616571 (Pubitemid 43890925)
16. ME Conley LD Notarangelo A Etzioni 1999 Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies) Clin Immunol 93 190 197 10.1006/clim.1999.4799 1:STN:280:DC%2BD3c%2FntFaitw%3D%3D 10600329
17. X Bossuyt GE Marti TA Fleisher 1997 Comparative analysis of whole blood lysis methods for flow cytometry Cytometry 30 124 133 10.1002/(SICI)1097- 0320(19970615)30:3<124::AID-CYTO3>3.0.CO;2-L 1:STN:280: DyaK2szmsFahug%3D%3D 9222098 (Pubitemid 27296733)
18. L Mouthon SV Kaveri SH Spalter S Lacroix-Desmazes C Lefranc R Desai MD Kazatchkine 1996 Mechanisms of action of intravenous immune globulin in immune-mediated diseases Clin Exp Immunol 104 suppl 1 3 9 1:CAS:528: DyaK28XjtVyiur8%3D 8625540
19. M Stangel KV Toyka R Gold 1999 Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases Arch Neurol 56 661 663 10.1001/archneur.56.6.661 1:STN:280:DyaK1M3psF2ktQ%3D%3D 10369303 (Pubitemid 29266463)
20. M Toyoda A Pao A Petrosian SC Jordan 2003 Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells Am J Transplant 3 156 166 10.1034/j.1600-6143.2003.00011.x 1:CAS:528: DC%2BD3sXis1Ghtrg%3D 12603211 (Pubitemid 36323113)
21. S von Gunten HU Simon 2008 Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg) Autoimmun Rev 7 453 456 10.1016/j.autrev. 2008.03.015
22. IN Van Schaik I Lundkvist M Vermeulen A Brand 1992 Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro J Clin Immunol 12 325 334 10.1007/BF00920789 1430102
23. IN Van Schaik M Vermeulen A Brand 1994 In vitro effects of polyvalent immunoglobulin for intravenous use J Neurol Neurosurg Psychiatry 57 15 17 10.1136/jnnp.57.Suppl.15 7964843
24. MR Alderson RJ Armitage E Maraskovsky TW Tough E Roux K Schooley F Ramsdell DH Lynch 1993 Fas transduces activation signals in normal human T lymphocytes J Exp Med 178 2231 2235 10.1084/jem.178.6.2231 1:CAS:528: DyaK3sXmt1Chsbc%3D 7504062 (Pubitemid 23344883)
25. J Iglesias N Matamoros S Raga JM Ferrer J Mila 1999 CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID): related to increased apoptosis Clin Exp Immunol 117 138 146 10.1046/j.1365-2249.1999.00946.x 1:CAS:528:DyaK1MXksl2it74%3D 10403927 (Pubitemid 29292789)
26. M Di Renzo Z Zhou I George K Becker C Cunningham-Rundles 2000 Enhanced apoptosis of T cells in common variable immunodeficiency. Role defective CD28 costimulation Clin Exp Immunol 120 503 511 10.1046/j.1365-2249.2000.01239.x 1:CAS:528:DC%2BD3cXkt1eqsbk%3D 10844530 (Pubitemid 30365557)
27. M Di Renzo D Serrano Z Zhou I George K Becker C Cunningham-Rundles 2001 Enhanced T-cell apoptosis in common variable immunodeficiency: negative role of the Fas/Fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS Clin Exp Immunol 125 117 122 10.1046/j.1365-2249.2001.01560.x 1:CAS:528:DC%2BD3MXmsVyit7w%3D 11472434 (Pubitemid 32703374)
28. O Aktas S Waiczies U Grieger U Wendling R Zschenderlein F Zipp 2001 Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto) antigen-specific T cells without inducing apoptosis J Neuroimmunol 114 160 167 10.1016/S0165-5728(01)00243-0 1:CAS:528:DC%2BD3MXhs1Cjtbk%3D 11240027 (Pubitemid 32184737)
29. KH Wu WM Wu MY Lu BL Chiang 2006 Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells Pediatr Allergy Immunol 17 60 68 10.1111/j.1399-3038.2005.00344.x 16426257